First Birth Control Pill For OTC Use In US Lands FDA Approval
Portfolio Pulse from Vandana Singh
Perrigo Company plc's (NYSE:PRGO) shares are trading higher after the FDA approved the company's Opill, a progestin-only daily oral contraceptive for over-the-counter use for all ages. Opill is the first-ever birth control pill available over the counter in the U.S. The pill will be available in-store and online at leading retailers across the U.S. early in the first quarter of 2024.
July 13, 2023 | 3:58 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Perrigo's shares are trading higher following the FDA approval of Opill, the first-ever over-the-counter birth control pill in the U.S. The product will be available in Q1 2024.
The FDA approval of Perrigo's Opill, the first-ever over-the-counter birth control pill in the U.S., is a significant milestone for the company. This approval opens a new market for Perrigo and could potentially boost its revenues. The news has already positively impacted the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100